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ABSTRACT 
 
Objective-Neurologic complications are frequent (30% -60%) in patients with end stage renal disease who have 
undergone renal transplant. There are very few longitudinal studies showing the effect neurologic problems have on 
the survival and quality of life in renal transplant recipients. This study sought to review the incidence and classify 
these complications. Methods- Patients of renal transplant (n=25) presenting to the renal transplant unit of a teaching 
tertiary care hospital were included in this study. A written informed consent was taken from all patients. Medical 
records and history were reviewed .Neurological assessment was done. Mental state was assessed based on a simple 
standardised questionnaire. Results-Out of the 25 patients examined, 23 (92%) were men and 2(8%) were women. 
The mean age of the recipients was 35±5 years (range 14-65 years). There were 11(44%) who had neurologic 
complications. Dementia was the commonest present in 3(12%) of our patients post transplant. Encephalopathy was 
observed in 3(12%) of our patients .Headache was present in 1 (4%) of our patients pre transplant. Conclusion-
Neurologic complications are common after renal transplant and are mainly associated with immunosuppressive 
medication. 
Keywords: Renal failure, immunosuppressants, neurotoxicity, neurologic complications, organ transplant. 
Introduction 
 
Renal transplant surgeries have become the best 
therapy for most patients with end stage renal disease. 
The five year patient survival rate has reached almost 
90% in many centres today. However , with increased 
survival , new diseases in the recipients are occurring 
and among these neurological disorders are not 
infrequent[1].Some neurological complications are 
caused by the inherent disorders that led to 
transplantation and / or by dialysis .The post transplant 
neurological complications are mainly due to the 
immunosuppressive therapy which may increase the 
risk of opportunistic infections and neurotoxicity . 
These complications constitute a serious concern for 
the morbidity and mortality of the recipients. The aim 
of the present study was to review the neurological 
complications in renal transplant patients.  
  _______________________________ 
*Correspondence  
Joginder Sidhu 
Associate professor, Department of Physiology, 
Dayanand medical college and hospital, Ludhiana, 
India 
Email: drjksidhu@yahoo.co.in 
This study was approved by the institutional ethics 
committee. 
Material and methods 
 
The study was conducted on patients of end stage renal 
disease who presented to the renal transplant unit of a 
tertiary care teaching hospital. Twenty five patients 
with end stage renal disease due to varying etiologies 
were included in the study. A written informed consent 
was taken from all the patients. The assessment 
methods were explained in detail to the patients’ .A 
complete neurological assessment was done and a 
proforma was filled. A detailed mental examination 
was performed to assess any psychiatric abnormality. 
This was a simple questionnaire based on daily 
activities. The record section of our hospital keeps a 
computerised record of all renal transplant patients. 
The charts and records of all these patients were 
reviewed and incidence of complications recorded and 
comparison of complications was done pre-transplant 
and post-transplant. The data obtained was statistically 
analysed. 
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Results 
Twenty five patients with end stage renal disease who 
had undergone successful renal transplant were 
included in the study .The demographic data of these 
patients are shown in table I .23 (92%) of the patients 
were males and 2 (8%) were females. Mean age of the 
recipients was 35 ±5 years range (14 – 65 years). 
Table 1: Age Distribution 
S.NO. AGE 
GROUP (yrs) 
NO. PERCENTAGE 
1 0-20 1 8.00 
2 21-30 10 40.00 
3 31-40 5 20.00 
4 41-50 2 8.00 
5 51-60 5 20.00 
6 61-70 1 4.00 
Total  25  
 
Table II shows etiologies of end stage renal disease. 
The commonest cause was hypertension in 18 (72%) of 
the patients. It was followed by diabetic nephropathy in 
4 (16%) of the patients and 3 (12%) had 
glomerulonephritis. 
Table 2: Etiologies of end stage renal disease 
S.NO Etiology No. Percentage 
1 Diabetic nephropathy 4 16.00 
2 Hypertension 18 72.00 
3 Glomerulonephritis 3 12.00 
Total  25  
 
   
 
Table III shows incidence of neurological complications. These were present in 11 (44%) of our patients and absent 
in 14 (56%) of the patients. 
Table 3: Incidence of neurological complications 
S.NO Neurological complications No Percentage 
1 Present 11 44.00 
2 Absent 14 56.00 
Total  25  
 
   
 
Table IV shows categorisation of neurological 
complications. Headache was present in 1 (4%) of our 
patients before the transplant but was not reported post 
transplant. Seizures were present in 2(8%) of the 
patients pre transplant .Tremors were reported in 1(4%) 
of the patients post transplant. Dementia was 
documented in 1(4%) of patients pre transplant and 
was also seen post transplant in 3 (12%) patients. 
Neuropathy was seen in 6(24%) of the patients post 
transplant and encephalopathy was characterized by 
confusion and loss of memory in 3 (12%) of our 
patients. 
 
Table 4: Categotisation of neurological complications 
S.NO: Category Pre-transplant Post-transplant 
 
 Number Percentage Number Percentage 
1 Headache 1 4.00   
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2 Seizures 2 8.00   
3 Tremors   1 4.00 
4 Dementia 1 4.00 3 12.00 
5 Encephalopathy   3 12.00 
6 Mono/polyneuropathy   6 24.00 
 
Discussion 
 
Organ transplant recipients are at risk for a variety of 
complications including cerebrovascular insults, 
infections, electrolyte disturbances, hypertension, 
encephalopathy and toxicity induced by 
immunosuppressive agents [2-4]. Neurologic 
complications are frequent post transplant and may 
largely contribute to morbidity and mortality [5-7]. 
Post transplant headache is a recognised complication 
of organ transplant both in the form of a denovo 
headache or worsening of a known migraine [8-10]. In 
the present study, headache was present in one patient 
before the transplant. Post transplant headache was not 
documented. 
Tremor is another common complication seen 
frequently after transplant. Some researchers found it 
to be present in 40% of their patients [11]. In our study 
only 1(4%) of the patients reported tremors. In most of 
the patients tremors is the result of immunosuppressive 
agents. However if severity of tremor is not significant 
and does not worsen the patient’s quality of life then 
there is a tendency to ignore the symptom 
.Encephalopathy is a severe adverse effect of 
immunosuppressants. These patients may bpresent with 
a decreased level of consciousness, headache, 
dysarthria, depression, mania, cortical blindness, visual 
hallucinations and seizures [12]. In our study 3 (12%)  
patients had encephalopathy. Another common 
neurological complication reported was neuropathy. 
Similar reports were also documented in 2% patients 
who developed femoral neuropathy. In this study 
neuropathy was mild in 6(24%) of the patients. 
Seizures were reported frequently in renal transplant 
patients. [13,14]. The cause of these could be metabolic 
disturbances or drug toxicity. In our studies 2(8%) 
patients had seizures pre transplant. 
Conclusion 
The present study showed that neurologic 
complications after renal transplant are common. As 
more than half of the neurologic complications occur 
during first 3 months after transplant, a careful follow 
up including monitoring for these will decrease the 
morbidity and mortality in renal transplant recipients. 
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